“Imperial College London
Funded by more than £3 million from five founding donors, the Imperial Centre for Psychedelic Research builds on over a decade of pioneering work in this area carried out at Imperial College London, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.
The launch of our new Centre for Psychedelic Research is a watershed moment in the renaissance of psychedelic research.
Dr Robin Carhart-Harris
Head of the Centre for Psychedelic Research
Led by Dr Robin Carhart-Harris , the Centre focuses on two main research themes: the use of psychedelics in mental health care; and as tools to probe the brain’s basis of consciousness. It will also investigate their potential for treating other conditions, including anorexia.
The Centre aims to develop a research clinic that could help to gather additional clinical evidence and become a prototype for the licensed psychedelic care facilities of the future. It represents a watershed moment for psychedelic science, symbolic of its now mainstream recognition. Psychedelics are set to have a major impact on neuroscience and psychiatry in the coming years, and the Centre operates at the forefront of one of the most exciting areas in medical science.”
Learn more at https://www.imperial.ac.uk/psychedelic-research-centre/about-us/